{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:16:37Z","timestamp":1784168197470,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100018493","name":"Taipei Medical University Shuang Ho Hospital","doi-asserted-by":"publisher","award":["110TMU-SHH-03"],"award-info":[{"award-number":["110TMU-SHH-03"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["108-2314-B-038-041"],"award-info":[{"award-number":["108-2314-B-038-041"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.lfs.2021.120172","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T11:57:17Z","timestamp":1637668637000},"page":"120172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The pathogenic role of IFN-\u03b1 in thyroiditis mouse models"],"prefix":"10.1016","volume":"288","author":[{"given":"Chao-Wen","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kam-Tsun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn-Diann","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2021.120172_bb0005","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1530\/EJE-11-1041","article-title":"An observational study of the initial management of hypothyroidism in France: the ORCHIDEE study","volume":"167","author":"Delemer","year":"2012","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120172_bb0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/er.2013-1055","article-title":"Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity","volume":"35","author":"McLachlan","year":"2014","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.lfs.2021.120172_bb0015","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/eje.0.1500605","article-title":"The environment and autoimmune thyroid diseases","volume":"150","author":"Prummel","year":"2004","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120172_bb0020","doi-asserted-by":"crossref","first-page":"J322","DOI":"10.1016\/j.jaut.2009.11.008","article-title":"Hepatitis C and interferon induced thyroiditis","volume":"34","author":"Tomer","year":"2010","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2021.120172_bb0025","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/0961203310371161","article-title":"The interferon-alpha signature of systemic lupus erythematosus","volume":"19","author":"Obermoser","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.lfs.2021.120172_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.4254\/wjh.v8.i2.83","article-title":"Hepatitis C virus infection and thyroid autoimmune disorders: a model of interactions between the host and the environment","volume":"8","author":"Pastore","year":"2016","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.lfs.2021.120172_bb0035","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0016-5085(03)00394-9","article-title":"Side effects of therapy for chronic hepatitis C","volume":"124","author":"Russo","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120172_bb0040","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/cen.14090","article-title":"Associations of gene polymorphisms in interferon-alpha signature-related genes with autoimmune thyroid diseases","volume":"91","author":"Lin","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120172_bb0045","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1038\/s41598-019-42442-0","article-title":"Effects of exogenous melatonin on clinical and pathological features of a human thyroglobulin-induced experimental autoimmune thyroiditis mouse model","volume":"9","author":"Lin","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2021.120172_bb0050","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1677\/JOE-09-0089","article-title":"Immunization with thyroglobulin induces Graves'-like disease in mice","volume":"202","author":"Endo","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120172_bb0055","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1006\/cimm.1998.1446","article-title":"Both CD4(+) T cells and CD8(+) T cells are required for iodine accelerated thyroiditis in NOD mice","volume":"192","author":"Hutchings","year":"1999","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.lfs.2021.120172_bb0060","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/j.1365-2265.2006.02629.x","article-title":"Clinical features and morphological characterization of 10 patients with noninsulinoma pancreatogenous hypoglycaemia syndrome (NIPHS)","volume":"65","author":"Won","year":"2006","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120172_bb0065","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/S0026-0495(03)00200-2","article-title":"Intra-arterial calcium stimulation test for detection of insulinomas: detection rate, responses of pancreatic peptides, and its relationship to differentiation of tumor cells","volume":"52","author":"Won","year":"2003","journal-title":"Metabolism"},{"key":"10.1016\/j.lfs.2021.120172_bb0070","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/1471-2105-6-232","article-title":"EXPANDER\u2013an integrative program suite for microarray data analysis","volume":"6","author":"Shamir","year":"2005","journal-title":"BMC bioinformatics"},{"key":"10.1016\/j.lfs.2021.120172_bb0075","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.lfs.2021.120172_bb0080","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1210\/endo.136.3.7867596","article-title":"Tumor necrosis factor-alpha and interferon-gamma modulate gene expression of type I 5'-deiodinase, thyroid peroxidase, and thyroglobulin in FRTL-5 rat thyroid cells","volume":"136","author":"Tang","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.lfs.2021.120172_bb0085","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1089\/107999000750053690","article-title":"Biologic responses to IFN-alpha administration in humans","volume":"20","author":"Corssmit","year":"2000","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.lfs.2021.120172_bb0090","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0167-5699(00)01710-2","article-title":"Type I interferons and T helper development","volume":"21","author":"Farrar","year":"2000","journal-title":"Immunol. Today"},{"key":"10.1016\/j.lfs.2021.120172_bb0095","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/gast.1997.v112.pm9041265","article-title":"New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine","volume":"112","author":"Tilg","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2021.120172_bb0100","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1158\/1078-0432.CCR-10-1114","article-title":"Direct effects of type I interferons on cells of the immune system","volume":"17","author":"Hervas-Stubbs","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2021.120172_bb0105","first-page":"399","article-title":"The risk factor for development of thyroid disease during interferon-alpha therapy for chronic hepatitis C","volume":"89","author":"Watanabe","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.lfs.2021.120172_bb0110","first-page":"922","article-title":"Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis","volume":"80","author":"Imagawa","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2021.120172_bb0115","first-page":"150","article-title":"The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD)","volume":"65","author":"Mikos","year":"2014","journal-title":"Endokrynol. Pol."},{"key":"10.1016\/j.lfs.2021.120172_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1480001","article-title":"Autoimmune thyroid disease: propagation and progression","volume":"148","author":"Weetman","year":"2003","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.lfs.2021.120172_bb0125","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1210\/jcem.84.10.6071","article-title":"The interaction of TSH receptor autoantibodies with 125I-labelled TSH receptor","volume":"84","author":"Sanders","year":"1999","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.lfs.2021.120172_bb0130","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.4049\/jimmunol.1502638","article-title":"Chronic type I IFN is sufficient to promote immunosuppression through accumulation of myeloid-derived suppressor cells","volume":"198","author":"Taleb","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.120172_bb0135","doi-asserted-by":"crossref","first-page":"7178","DOI":"10.4049\/jimmunol.0802526","article-title":"Multiple mechanisms contribute to impairment of type 1 interferon production during chronic lymphocytic choriomeningitis virus infection of mice","volume":"182","author":"Lee","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.lfs.2021.120172_bb0140","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/nature13554","article-title":"Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression","volume":"511","author":"Sandler","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2021.120172_bb0145","first-page":"3544","article-title":"Nonpathogenic SIV infection of african green monkeys induces a strong but rapidly controlled type I IFN response","volume":"119","author":"Jacquelin","year":"2009","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.lfs.2021.120172_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2021.120172_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2016.01.001","article-title":"Type I interferons in viral control and immune regulation","volume":"16","author":"Teijaro","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.lfs.2021.120172_bb0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1126\/science.1235208","article-title":"Blockade of chronic type I interferon signaling to control persistent LCMV infection","volume":"340","author":"Wilson","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.lfs.2021.120172_bb0165","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1126\/science.1235214","article-title":"Persistent LCMV infection is controlled by blockade of type I interferon signaling","volume":"340","author":"Teijaro","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.lfs.2021.120172_bb0170","first-page":"161","article-title":"The effects of alpha interferon on the development of autoimmune thyroiditis in the NOD H2h4 mouse","volume":"10","author":"Oppenheim","year":"2003","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.lfs.2021.120172_bb0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jhep.2013.11.003","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60","year":"2014","journal-title":"J. Hepatol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521011590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:21:48Z","timestamp":1778642508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521011590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":35,"alternative-id":["S0024320521011590"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120172","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenic role of IFN-\u03b1 in thyroiditis mouse models","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.120172","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120172"}}